NMS is strategically committed to setting up partnerships in an endeavour to promote discovery and development of innovative cancer treatments as well as to outlicense discovery projects at different stages of preclinical and clinical development.

NMS proposes to establish R&D collaborative undertakings with the aim of discovering and developing novel targeted cancer treatments.

With its technology platforms, company aims to set up focused discovery alliances in the field of oncology with biotech and pharma companies and with academia , thus expanding the company's already established pipeline.

See more on Collaborations and Licenses .